Last week, CHPA, the American Herbal Products Association, the Council for Responsible Nutrition, and the United Natural Products Alliance sent a letter to Senators Tammy Baldwin (D-Wisc.) and John Hoeven (R-N.D.), the Chair and Ranking Member of the Appropriations Subcommittee that has jurisdiction over FDA funding, highlighting the need for additional resources for the Office of Dietary Supplement Programs at FDA due to the growing dietary supplement market.
COVID-19 has taught us a lot about minimizing our risk and focusing on wellness and prevention in our lives. Anita and John dig into what this shift means to the dietary supplements category of the consumer healthcare industry.
This week, CHPA submitted written testimony in opposition to California Assembly Bill 1341, which prohibits individuals under the age of 18 from buying dietary supplements and OTC drugs for weight loss.